SU11248A1
(ru)
|
1927-03-29 |
1929-09-30 |
В.С. Григорьев |
Способ очистки антрацена
|
US2908677A
(en)
|
1955-03-30 |
1959-10-13 |
Eastman Kodak Co |
Nickel and cobalt complexes of pyrazolone monoazo compounds
|
US3428634A
(en)
|
1965-03-13 |
1969-02-18 |
Acraf |
3-tertiary amino alkoxy-1-hydrocarbon indazoles
|
CH471199A
(de)
|
1965-07-06 |
1969-04-15 |
Sandoz Ag |
Verfahren zur Herstellung metallhaltiger Azofarbstoffe
|
DE2313722B2
(de)
|
1973-03-20 |
1977-08-11 |
Bayer Ag, 5090 Leverkusen |
Chromischkomplex-farbstoffe und ihre verwendung zum faerben und bedrucken von stickstoffhaltigen fasermaterialien
|
IT1005472B
(it)
|
1974-02-15 |
1976-08-20 |
Montedison Spa |
Procedimento per la preparazione del 2,5, dimetil 3,2h, furanone
|
DE2460891C2
(de)
|
1974-12-21 |
1982-09-23 |
Gödecke AG, 1000 Berlin |
1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
|
FR2301250A1
(fr)
|
1975-02-21 |
1976-09-17 |
Bellon Labor Sa Roger |
Nouveaux diaryl-1, 4o-aminoalcoxy-3 pyrazoles et leurs sels
|
CA1121651A
(en)
|
1978-07-27 |
1982-04-13 |
Chi-Kuen Shu |
2,5-dialkyl dihydrofuranones and 2,4,5-trialkyl dihydrofuranones, mixtures of same and organoleptic uses thereof
|
US4207392A
(en)
|
1978-10-30 |
1980-06-10 |
Eastman Kodak Company |
Heat developable and stabilizable photographic materials and process
|
FR2460299A1
(fr)
|
1979-07-05 |
1981-01-23 |
Bellon Labor Sa Roger |
Nouveaux derives du pyrazole et leur application therapeutique
|
US4234616A
(en)
|
1979-08-03 |
1980-11-18 |
International Flavors & Fragrances Inc. |
Flavoring with mixtures of 2,5-dialkyl dihydrofuranones and 2,4,5-trialkyl dihydrofuranones
|
FR2472564A1
(fr)
|
1979-12-31 |
1981-07-03 |
Bellon Labor Sa Roger |
Nouveaux aryl-1 arylsulfonyl-4 1h-pyrazolols-3, et procede pour les preparer
|
US4826868A
(en)
|
1986-05-29 |
1989-05-02 |
Ortho Pharmaceutical Corporation |
1,5-Diaryl-3-substituted pyrazoles pharmaceutical compositions and use
|
GB8917069D0
(en)
|
1989-07-26 |
1989-09-13 |
Merck Sharp & Dohme |
Therapeutic agents
|
IL96507A0
(en)
|
1989-12-08 |
1991-08-16 |
Merck & Co Inc |
Nitrogen-containing spirocycles and pharmaceutical compositions containing them
|
EP0507863A4
(en)
|
1989-12-28 |
1993-07-07 |
Virginia Commonwealth University |
Sigma receptor ligands and the use thereof
|
JPH03232817A
(ja)
|
1990-02-07 |
1991-10-16 |
Showa Yakuhin Kako Kk |
貼付剤
|
EP0445974A3
(en)
|
1990-03-05 |
1992-04-29 |
Merck Sharp & Dohme Ltd. |
Spirocyclic antipsychotic agents
|
JPH04364129A
(ja)
|
1990-10-26 |
1992-12-16 |
Asahi Chem Ind Co Ltd |
6−置換アルコキシキノキサリン誘導体含有医薬組成物およびその製造法
|
AU9137091A
(en)
|
1990-11-27 |
1992-06-25 |
Northwestern University |
Gaba and l-glutamic acid analogs for antiseizure treatment
|
NZ243065A
(en)
|
1991-06-13 |
1995-07-26 |
Lundbeck & Co As H |
Piperidine derivatives and pharmaceutical compositions
|
US5240925A
(en)
|
1991-08-26 |
1993-08-31 |
Rohm And Haas Company |
Fungicidal 2-aryl-2-cyano-2-(heterocyclylalkyl)ethyl-1,2,4-triazoles
|
DK0641330T3
(da)
|
1992-05-20 |
2001-12-03 |
Univ Northwestern |
Gaba- og L-glutaminsyreanaloger til antikrampeanfaldsbehandling
|
GB9423542D0
(en)
|
1994-11-22 |
1995-01-11 |
Marples Brian A |
Pharmaceutical compounds
|
JPH1036259A
(ja)
|
1996-04-11 |
1998-02-10 |
Kikkoman Corp |
白内障の予防または治療薬剤
|
JPH1055048A
(ja)
|
1996-08-08 |
1998-02-24 |
Fuji Photo Film Co Ltd |
ハロゲン化銀写真感光材料
|
EP0971588B1
(en)
|
1997-01-21 |
2004-03-17 |
Smithkline Beecham Corporation |
Novel cannabinoid receptor modulators
|
JP2001516361A
(ja)
|
1997-03-18 |
2001-09-25 |
スミスクライン・ビーチャム・コーポレイション |
新規カンナビノイド受容体作動薬
|
JP2001518912A
(ja)
|
1997-04-14 |
2001-10-16 |
ソルフォード、ウルトラファイン、ケミカルズ、アンド、リサーチ、リミテッド |
モルヒネ誘導体
|
JP2000513383A
(ja)
|
1997-07-02 |
2000-10-10 |
メルク エンド カンパニー インコーポレーテッド |
タキキニン受容体拮抗薬2−(r)−(1−(r)−(3,5−ビス(トリフルオロメチル)フェニル)エトキシ)−3−(s)−(4−フルオロ)フェニル−4−(3−(5−オキソ−1h,4h−1,2,4−トリアゾロ)メチルモルホリンの多形結晶
|
CU23048A3
(es)
|
1997-10-27 |
2005-06-24 |
Warner Lambert Co |
Aminoacidos ciclicos y derivados de los mismos, utiles como agentes farmaceuticos
|
PT1047678E
(pt)
|
1997-12-16 |
2004-12-31 |
Warner Lambert Co |
Derivados do 1-aminometil-cicloalcano substituido em 1 (=analogos da gabapentina) sua preparacao e sua utilizacao no tratamento de disturbios neurologicos
|
IL135315A0
(en)
|
1997-12-16 |
2001-05-20 |
Warner Lambert Co |
4(3)-substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (gabapentin analogues), their preparation and their use in the treatment of neurological disorders
|
CA2304965C
(en)
|
1997-12-16 |
2007-08-21 |
Warner-Lambert Company |
((cyclo)alkyl substituted)-gamma-aminobutyric acid derivatives (=gaba analogues), their preparation and their use in the treatment of neurological disorders
|
WO1999059409A1
(en)
|
1998-05-21 |
1999-11-25 |
Matsumoto Rae R |
Compounds and uses thereof
|
AU757445B2
(en)
|
1998-05-26 |
2003-02-20 |
Warner-Lambert Company |
Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel
|
US6166072A
(en)
|
1998-08-03 |
2000-12-26 |
Allelix Neuroscience, Inc. |
Amino acid derivatives
|
AU9553898A
(en)
|
1998-10-01 |
2000-04-26 |
Egis Gyogyszergyar Rt. |
Pharmaceutical compositions containing an opiate analgesic and a synergizing substance
|
GB9824310D0
(en)
|
1998-11-05 |
1998-12-30 |
Univ London |
Activators of soluble guanylate cyclase
|
CA2349452C
(en)
|
1998-11-09 |
2009-02-10 |
Santen Pharmaceutical Co., Ltd. |
Therapeutic agents for drug dependence
|
WO2000031020A1
(en)
|
1998-11-25 |
2000-06-02 |
Warner-Lambert Company |
Improved gamma amino butyric acid analogs
|
NO310544B1
(no)
|
1999-01-04 |
2001-07-23 |
Algeta As |
Opparbeidelse og anvendelse av radium-223 til fremstilling av preparat samt kit til behandling av kalsifisert vev for palliasjon, benkreft-terapi og/eller overflatebehandling av ben
|
CA2359485A1
(en)
|
1999-03-10 |
2000-09-14 |
Warner-Lambert Company |
Analgesic compositions comprising anti-epileptic compounds and methods of using same
|
CA2373210A1
(en)
|
1999-05-26 |
2000-12-07 |
Warner-Lambert Company |
Fused polycyclic amino acids as pharmaceutical agents
|
ES2234599T3
(es)
|
1999-05-28 |
2005-07-01 |
Warner-Lambert Company Llc |
Analogos de gaba sustituidos con 3-heteroarilaquilo.
|
ATE228128T1
(de)
|
1999-06-02 |
2002-12-15 |
Warner Lambert Co |
Amino-heterocyclen zur verwendung als pharmazeutische mittel
|
US7091257B2
(en)
|
1999-07-27 |
2006-08-15 |
Alcatel |
Radiation-curable composition with simultaneous color formation during cure
|
US6469030B2
(en)
|
1999-11-29 |
2002-10-22 |
Adolor Corporation |
Methods for the treatment and prevention of ileus
|
US6492529B1
(en)
|
2000-01-18 |
2002-12-10 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Bis pyrazole-1H-pyrazole intermediates and their synthesis
|
US6965019B2
(en)
|
2000-04-03 |
2005-11-15 |
Sun Chemical Corporation |
Mono-and bis-hydrazone pigments
|
WO2002085839A1
(en)
|
2001-04-19 |
2002-10-31 |
Warner-Lambert Company Llc |
Fused bicyclic or tricyclic amino acids
|
CA2446864C
(en)
|
2001-05-16 |
2011-02-15 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of src and other protein kinases
|
WO2002102387A1
(en)
|
2001-06-18 |
2002-12-27 |
H. Lundbeck A/S |
Treatment of neuropathic pain
|
US6509367B1
(en)
|
2001-09-22 |
2003-01-21 |
Virginia Commonwealth University |
Pyrazole cannabinoid agonist and antagonists
|
RU2218187C2
(ru)
|
2002-02-11 |
2003-12-10 |
Ростовский научно-исследовательский онкологический институт |
Способ лечения болевого синдрома у онкологических больных
|
GB0206505D0
(en)
|
2002-03-19 |
2002-05-01 |
Euro Celtique Sa |
Pharmaceutical combination
|
AU2003265395A1
(en)
|
2002-08-14 |
2004-03-03 |
Ppd Discovery, Inc. |
Prenylation inhibitors and methods of their synthesis and use
|
TW200413351A
(en)
|
2002-08-21 |
2004-08-01 |
Astrazeneca Ab |
Chemical compounds
|
ATE469143T1
(de)
|
2002-11-15 |
2010-06-15 |
Du Pont |
Neue insektizide vom anthranilamid-typ
|
JP2004196678A
(ja)
|
2002-12-17 |
2004-07-15 |
Dainippon Pharmaceut Co Ltd |
ピラゾール系誘導体
|
US7135575B2
(en)
|
2003-03-03 |
2006-11-14 |
Array Biopharma, Inc. |
P38 inhibitors and methods of use thereof
|
WO2004110387A2
(en)
|
2003-06-12 |
2004-12-23 |
Agy Therapeutics, Inc. |
Sigma ligands for neuronal regeneration and functional recovery
|
WO2005061462A2
(en)
|
2003-12-19 |
2005-07-07 |
Neurogen Corporation |
Diaryl pyrazole derivatives and their use as neurokinin-3 receptor modulators
|
WO2006010587A1
(en)
|
2004-07-24 |
2006-02-02 |
Laboratorios Del Dr. Esteve, S.A. |
Use of compounds active on the sigma receptor for the treatment of mechanical allodynia
|
BRPI0514736A
(pt)
|
2004-08-27 |
2008-06-24 |
Esteve Labor Dr |
inibidores do receptor sigma
|
EP1634872A1
(en)
|
2004-08-27 |
2006-03-15 |
Laboratorios Del Dr. Esteve, S.A. |
Pyrazole derivatives as sigma receptor inhibitors
|
JP5139061B2
(ja)
|
2004-08-27 |
2013-02-06 |
ラボラトリオス デル ドクトール エステベ エセ.ア. |
シグマ受容体阻害剤
|
ES2251316B1
(es)
|
2004-10-14 |
2007-03-16 |
Laboratorios Del Dr. Esteve, S.A. |
Inhibidores del receptor sigma.
|
RU2417987C2
(ru)
|
2004-08-27 |
2011-05-10 |
Лабораторьос Дель Др.Эстеве, С.А. |
Ингибиторы сигма-рецептора
|
EP1634873A1
(en)
|
2004-08-27 |
2006-03-15 |
Laboratorios Del Dr. Esteve, S.A. |
Sigma receptor inhibitors
|
EP1632227A1
(en)
|
2004-09-07 |
2006-03-08 |
Laboratorios del Dr. Esteve S.A. |
Derivatives of aryl (or heteroaryl) azolylcarbinols (in particular cizolirtin citrate) for the treatment of opioid addiction
|
US20080161604A1
(en)
|
2005-04-26 |
2008-07-03 |
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. |
Acetyl L-Carnitine For Preventing Painful Peripheral Diabetic Neuropathy
|
JP2008179541A
(ja)
|
2005-05-02 |
2008-08-07 |
Mochida Pharmaceut Co Ltd |
神経因性疼痛治療薬
|
ITRM20050332A1
(it)
|
2005-06-24 |
2006-12-25 |
Lay Line Genomics Spa |
Uso di molecole in grado di bloccare l'attivita' di trka per potenziare gli effetti di analgesici oppiacei sul dolore.
|
SG162804A1
(en)
|
2005-06-27 |
2010-07-29 |
Exelixis Inc |
Pyrazole based lxr modulators
|
US20090325975A1
(en)
|
2005-07-15 |
2009-12-31 |
Helmut H Buschmann |
Use of compounds binding to the sigma receptor for the treatment of diabetes-associated pain
|
EP1787679A1
(en)
|
2005-07-29 |
2007-05-23 |
Laboratorios Del Dr. Esteve, S.A. |
Use of compounds binding to the sigma receptor for the treatment of diabetes-associated pain
|
WO2007041593A2
(en)
|
2005-10-03 |
2007-04-12 |
Combinatorx, Incorporated |
Anti-scarring drug combinations and use thereof
|
US7872006B2
(en)
|
2005-10-21 |
2011-01-18 |
Mitsubishi Tanabe Pharma Corporation |
Pyrazole compounds having cannabinoid receptor (CB1) antagonizing activity
|
WO2007079086A1
(en)
|
2005-12-28 |
2007-07-12 |
Coley Pharmaceutical Group, Inc. |
Pyrazoloalkyl substituted imidazo ring compounds and methods
|
EP1820502A1
(en)
|
2006-02-10 |
2007-08-22 |
Laboratorios Del Dr. Esteve, S.A. |
Active substance combination comprising azolylcarbinol compounds
|
EP1991211A1
(en)
|
2006-02-28 |
2008-11-19 |
Laboratorios Del Dr. Esteve, S.A. |
Use of compounds binding to the sigma receptor for the treatment of metabolic syndrome
|
EP1994032A1
(en)
|
2006-03-01 |
2008-11-26 |
Laboratorios del Dr. Esteve S.A. |
Pyrazole derivatives as sigma receptor inhibitors
|
EP1829875A1
(en)
|
2006-03-01 |
2007-09-05 |
Laboratorios Del Dr. Esteve, S.A. |
Pyrazole derivatives as sigma receptor inhibitors
|
EP1829873A1
(en)
|
2006-03-02 |
2007-09-05 |
Laboratorios Del Dr. Esteve, S.A. |
Pyrrazole derivatives as sigma receptors antagonists
|
EP1829866A1
(en)
|
2006-03-02 |
2007-09-05 |
Laboratorios Del Dr. Esteve, S.A. |
Sigma receptor inhibitors
|
JP5017256B2
(ja)
|
2006-03-22 |
2012-09-05 |
パナソニック株式会社 |
血液検査装置
|
EP2394646B1
(en)
|
2006-03-27 |
2018-07-25 |
Wex Medical Limited |
Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy
|
EP1847542A1
(en)
|
2006-04-21 |
2007-10-24 |
Laboratorios del Dr. Esteve S.A. |
Spiro[benzopyran] or spiro[benzofuran] derivatives which inhibit the sigma receptor
|
WO2007141018A1
(en)
|
2006-06-08 |
2007-12-13 |
Schwarz Pharma Ag |
Therapeutic combination for painful medical conditions
|
RU2322977C1
(ru)
|
2006-08-01 |
2008-04-27 |
Закрытое акционерное общество "Физиофарм" |
Синтетическое анальгетическое средство и способ лечения на основе этого средства
|
CA2660028A1
(en)
|
2006-08-04 |
2008-02-07 |
Laboratorios Del Dr. Esteve, S.A. |
Substituted dimethylcyclobutyl compounds, their preparation and use in medicaments
|
US7645767B2
(en)
|
2006-08-31 |
2010-01-12 |
Trinity Laboratories, Inc. |
Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
|
EP1921071A1
(en)
|
2006-11-10 |
2008-05-14 |
Laboratorios del Dr. Esteve S.A. |
1,2,3- triazole derivatives as sigma receptor inhibitors
|
EP1921073A1
(en)
|
2006-11-10 |
2008-05-14 |
Laboratorios del Dr. Esteve S.A. |
1,2,4-Triazole derivatives as sigma receptor inhibitors
|
US20090018151A1
(en)
|
2007-02-23 |
2009-01-15 |
Ezekiel Fink |
Topical Treatment of Peripheral diabetic complications
|
KR100868353B1
(ko)
|
2007-03-08 |
2008-11-12 |
한국화학연구원 |
도파민 d4 수용체 길항제인 신규 피페라지닐프로필피라졸유도체, 이의 제조방법 및 이를 포함하는 약학적 조성물
|
GB0710981D0
(en)
|
2007-06-07 |
2007-07-18 |
Acacia Pharma Ltd |
New Therapeutic use
|
US20100240711A1
(en)
|
2007-09-21 |
2010-09-23 |
Shionogi & Co., Ltd. |
Solid preparation comprising npyy5 receptor antagonist
|
EP2070933A1
(en)
|
2007-12-07 |
2009-06-17 |
Laboratorios del Dr. Esteve S.A. |
Tricyclic triazolic compounds
|
EP2090311A1
(en)
|
2008-02-18 |
2009-08-19 |
Laboratorios Del. Dr. Esteve, S.A. |
Use of compounds binding to the sigma receptor ligands for the treatment of neuropathic pain developing as a consequence of chemotherapy
|
PT2254579T
(pt)
|
2008-02-18 |
2018-04-16 |
Esteve Labor Dr |
Utilização de compostos que se ligam aos ligandos de recetor sigma para o tratamento de dor neuropática que se desenvolve como uma consequência de quimioterapia
|
EP2116539A1
(en)
*
|
2008-04-25 |
2009-11-11 |
Laboratorios Del. Dr. Esteve, S.A. |
1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof
|
EP2112139A1
(en)
|
2008-04-25 |
2009-10-28 |
Laboratorios Del. Dr. Esteve, S.A. |
Process for the preparation of naphthalen-2-yl-pyrazol-3-one intermediates useful in the synthesis of sigma receptor inhibitors
|
EP2113501A1
(en)
|
2008-04-25 |
2009-11-04 |
Laboratorios Del. Dr. Esteve, S.A. |
5-Methyl-1-(naphthalen-2-YL)-1H-Pyrazoles useful as sigma receptor inhibitors
|
RU2382646C1
(ru)
|
2008-11-20 |
2010-02-27 |
Федеральное государственное учреждение "Московский научно-исследовательский онкологический институт им. П.А. Герцена Федерального агентства по высокотехнологичной медицинской помощи" |
Способ профилактики и лечения послеоперационного болевого синдрома при обширных торакоабдоминальных операциях
|
US8192885B2
(en)
|
2009-01-26 |
2012-06-05 |
GM Global Technology Operations LLC |
Shutdown strategy for enhanced water management
|
EP2292236A1
(en)
|
2009-08-14 |
2011-03-09 |
Laboratorios Del. Dr. Esteve, S.A. |
Sigma ligands for the prevention or treatment of pain induced by chemotherapy
|
KR20130004244A
(ko)
|
2009-11-25 |
2013-01-09 |
라보라토리오스 델 드라. 에스테브.에스.에이. |
4-[2-[[5-메틸-1-(2-나프탈레닐)-1h-피라졸-3-일]옥시]에틸]모르폴린염
|
EP2361904A1
(en)
|
2010-02-04 |
2011-08-31 |
Laboratorios Del. Dr. Esteve, S.A. |
4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride and crystalline forms thereof
|
EP2335688A1
(en)
|
2009-11-25 |
2011-06-22 |
Laboratorios Del. Dr. Esteve, S.A. |
Pharmaceutical compositions comprising sigma receptor ligands
|
EP2353598A1
(en)
|
2010-02-04 |
2011-08-10 |
Laboratorios Del. Dr. Esteve, S.A. |
Sigma ligands for use in the prevention and/or treatment of postoperative pain
|
EP2426112A1
(en)
|
2010-08-09 |
2012-03-07 |
Laboratorios Del. Dr. Esteve, S.A. |
4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride polymorphs and solvates
|
RU2560150C2
(ru)
|
2010-02-04 |
2015-08-20 |
Лабораторьос Дель Др. Эстеве, С.А. |
Полиморфы и сольваты гидрохлорида 4-[2-[[5-метил-1-(2-нафталинил)-1н-пиразол-3-ил]окси]этил]морфолина
|
EP2353591A1
(en)
|
2010-02-04 |
2011-08-10 |
Laboratorios Del. Dr. Esteve, S.A. |
Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof
|
US20110269727A1
(en)
|
2010-04-29 |
2011-11-03 |
Toledano Annette C |
Composition to reduce allodynic back pain and related method of use
|
EP2388005A1
(en)
|
2010-05-21 |
2011-11-23 |
Laboratorios Del. Dr. Esteve, S.A. |
Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy
|
EP2395003A1
(en)
|
2010-05-27 |
2011-12-14 |
Laboratorios Del. Dr. Esteve, S.A. |
Pyrazole compounds as sigma receptor inhibitors
|
EP2415471A1
(en)
|
2010-08-03 |
2012-02-08 |
Laboratorios Del. Dr. Esteve, S.A. |
Use of sigma ligands in opioid-induced hyperalgesia
|
EP2426111A1
(en)
*
|
2010-08-09 |
2012-03-07 |
Laboratorios Del. Dr. Esteve, S.A. |
4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride amorphous solid forms
|
EP2460804A1
(en)
|
2010-12-03 |
2012-06-06 |
Laboratorios Del Dr. Esteve, S.A. |
5-methyl-1-(naphthalen-2-yl)-1h-pyrazole derivatives and their use in potentiating the effect of opioid analgesics
|
EP2460519A1
(en)
|
2010-12-03 |
2012-06-06 |
Laboratorios Del. Dr. Esteve, S.A. |
Use of sigma ligands in bone cancer pain
|
LT2712358T
(lt)
|
2011-05-13 |
2017-01-25 |
Array Biopharma, Inc. |
Pirolidinilkarbamido, pirolidiniltiokarbamido ir pirolidinilguanidino junginiai kaip trka kinazės inhibitoriai
|
EP2524694A1
(en)
*
|
2011-05-19 |
2012-11-21 |
Laboratorios Del. Dr. Esteve, S.A. |
Use of sigma ligands in diabetes type-2 associated pain
|
EP2792352A1
(en)
|
2013-04-16 |
2014-10-22 |
Laboratorios Del. Dr. Esteve, S.A. |
Alpha-2 adrenoreceptor and sigma receptor ligand combinations
|
EP2818166A1
(en)
|
2013-06-26 |
2014-12-31 |
Laboratorios del Dr. Esteve S.A. |
Use of sigma receptor ligands for the prevention and treatment of pain associated to interstitial cystitis/bladder pain syndrome (IC/BPS)
|
TN2016000084A1
(en)
|
2013-09-12 |
2017-07-05 |
Esteve Labor Dr |
Nsaid and sigma receptor ligand combinations
|
BR112016013754A2
(pt)
|
2013-12-17 |
2017-08-08 |
Esteve Labor Dr |
Recaptação de serotonina-norepinefrina inibidores (irsns) e combinações dos ligantes do receptor sigma
|
WO2015091505A1
(en)
|
2013-12-17 |
2015-06-25 |
Laboratorios Del Dr. Esteve, S.A. |
Gabapentinoids and sigma receptor ligands combinations
|